IHS Chemical Week

Regions :: Southeast Asia :: Singapore

Lonza Completes Arch Deal; Lists on Singapore Stock Exchange

6:44 AM MDT | October 20, 2011 | Kerri Walsh

Lonza has completed its acquisition of Arch Chemicals for $1.4 billion, or $47.20/share. Lonza says it owns more than 90% of Arch’s outstanding shares, and expects to complete the deal through a short-form merger no later than October 21. Upon completion of the merger, Arch will become an indirect, wholly-owned subsidiary of Lonza.   The acquisition creates the largest biocides business, and expands Lonza’s non-pharma life science business, says Lonza CEO Stefan Borgas. “After having built the world's leading pharmaceutical contract...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa